North American Automated Breast Ultrasound System Market size is predicted to reach USD 780 million by 2028, according to a latest forecast report by Graphical Research.
The number of breast cancer cases are rising in the U.S. & Canada, which will drive the adoption of ABUS and ABVS. According to the Breast Cancer Research Foundation (BCRF), as of 2022, around 290,560 individuals in the U.S. were diagnosed with breast cancer. The high prevalence will accelerate the demand for innovative imaging technologies that enable effective breast cancer treatment.
Conventional mammography has certain limitations with respect to visualizing dense breast tissues in women, as the technology creates a masking effect while detecting tumors. it has fueled the demand for ABUS to bypass these constraints. A key factor restraining the availability and access to automated breast imaging systems is the high cost associated the products.
The ABUS segment will surpass USD 520 million by 2028, owing to the ability of these devices to generate high-quality images during diagnosis. ABUS can produce 3D images of breast tissues in the shortest time possible and has greater sensitivity over mammography systems. It helps oncologists get a better idea about the severity of the condition and create an effective treatment plan accordingly.
The hospital end-user segment will display over 14.5% CAGR during the forecast timeframe of 2022-2028. The percentage of people diagnosed with breast cancer is growing at a worrying rate across the region. However, hospitals have skilled professionals to tend to the patient’s medical needs. These institutes are also equipped with technologically advanced machines, thereby increasing the patient footfall.
Browse detailed statistical insights from the report, “North America Automated Breast Ultrasound Systems (ABUS) Market Forecast 2028 By Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), By End-Use (Hospitals, Diagnostic Imaging Centers), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
U.S. ABUS industry share will grow at a robust pace up to 2028. The country is witnessing an alarming rise in the prevalence of breast cancer. As per the Breast Cancer Research Foundation (BCRF), as of 2022, about 287,850 women in the U.S. would be diagnosed with breast cancer, with an estimated 43,250 predicted to die from the ailment. The U.S. government is providing strong financial support to cancer research institutes, which will positively impact the production of next-gen automated breast ultrasound systems.
For instance, in May 2022, the U.S. Department of Health and Human Services (HHS) announced funding worth USD 5 million for community health centers across the country. These funds will be utilized to facilitate efficient cancer screening and early detection.
North America automated breast ultrasound system (ABUS) industry will record significant gains in the coming years, as more women become aware of the significance of going for regular health check-ups and early detection of tumors. With hospitals and diagnostic imaging centers across the region undergoing a notable infrastructure transformation, the demand for ABVS will grow considerably.
The automated breast ultrasound system in North American market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2017 to 2028, for the following segments:
North America Market, By Product
- Automated Breast Ultrasound System (ABUS)
- Automated Breast Volume Scanner (ABVS)
North America Market, By End-use
- Diagnostic Imaging Centers
The above information has been provided for the following countries: